Catalyst Wire Dossier Catalyst Wire Dossier

Peanut SLIT-tablet

peanut extract sublingual immunotherapy tablet · ALK-Abelló A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Peanut SLIT-tablet, covering 2026-03-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy [Phase 1, Phase 2]

See pricing